【4503】アステラス製薬 : Astellas and MSD Enter Co-Promotion Agreement in Japan for Ipragliflozin, SGLT2 Inhibitor for Treatment of Type 2 Diabetes

Astellas and MSD Enter Co-Promotion Agreement in Japan for Ipragliflozin, SGLT2 Inhibitor for Treatment of Type 2 Diabetes

出所:株経通信(株式会社みんかぶ)
PDFをダウンロード